Lamivudine bulk supplier for pharma manufacturers

Lamivudine Suppliers & Bulk Manufacturers

Available Forms: Tablet & Oral solution

Available Strengths: Tab:150 mg, 300 mg; Oral solution:10 mg/mL

Reference Brands: Epivir®(US/EU)

Lamivudine Tablets (100 mg–300 mg) are used to treat HIV and Hepatitis B. PharmaB2B connects global buyers with WHO-GMP and USFDA-approved suppliers for bulk, compliant procurement. Ideal for tenders and institutional use, Lamivudine ensures accessible, high-quality treatment in public health programs.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Lamivudine Tablets are essential antiretrovirals used in the treatment of HIV-1 and chronic Hepatitis B infection. Available in 100 mg, 150 mg, and 300 mg strengths, Lamivudine is part of the WHO Essential Medicines list and widely used in global ART programs. On PharmaB2B platforms, healthcare buyers and procurement agencies can source Lamivudine in bulk from WHO-GMP and USFDA-approved manufacturers. Ideal for NGOs, hospitals, and government tenders, Lamivudine is available as both standalone and fixed-dose combination therapy. Connect with trusted suppliers for quality-assured, cost-effective ARV solutions to support HIV and HBV care worldwide.

Lamivudine — third party manufacturing & bulk supply

Lamivudine is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Lamivudine is supplied as Tablet & Oral solution — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Lamivudine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Lamivudine →

Back to Listing

Frequently Asked Questions

Lamivudine is used to treat HIV-1 infection and chronic hepatitis B. It helps decrease viral load, improve immune function, and slow disease progression when used as part of combination antiviral therapy.

Lamivudine is made from the active nucleoside reverse transcriptase inhibitor (NRTI) compound lamivudine, a synthetic analogue of cytidine.

The well-known trade names include Epivir for HIV treatment and Epivir-HBV for hepatitis B.

Epivir and Epivir-HBV are manufactured by GlaxoSmithKline (GSK) and ViiV Healthcare. Many generic manufacturers worldwide also produce lamivudine.

The generic name is lamivudine.

Common brand names include Epivir and Epivir-HBV.

Lamivudine is manufactured in various approved pharmaceutical facilities worldwide, including the UK, USA, and multiple countries in Europe and Asia, depending on the company and market.